Effects of Zerlasiran on Lipoprotein(a) Serum Concentrations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Zerlasiran-A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial
JAMA 2024 Nov 18;[EPub Ahead of Print], SE Nissen, Q Wang, SJ Nicholls, AM Navar, KK Ray, GG Schwartz, M Szarek, ESG Stroes, R Troquay, JAN Dorresteijn, H Fok, DA Rider, S Romano, K Wolski, C RambaranFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.